These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24265799)

  • 21. Lipidation and PEGylation Strategies to Prolong the
    Gomez-Soler M; Olson EJ; de la Torre ER; Zhao C; Lamberto I; Flood DT; Danho W; Lechtenberg BC; Riedl SJ; Dawson PE; Pasquale EB
    Eur J Med Chem; 2023 Dec; 262():. PubMed ID: 38523699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and characterization of Nanobodies targeting the EphA4 receptor.
    Schoonaert L; Rué L; Roucourt B; Timmers M; Little S; Chávez-Gutiérrez L; Dewilde M; Joyce P; Curnock A; Weber P; Haustraete J; Hassanzadeh-Ghassabeh G; De Strooper B; Van Den Bosch L; Van Damme P; Lemmens R; Robberecht W
    J Biol Chem; 2017 Jul; 292(27):11452-11465. PubMed ID: 28526745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of the receptor tyrosine kinase EphA4 in human gastric cancers.
    Oki M; Yamamoto H; Taniguchi H; Adachi Y; Imai K; Shinomura Y
    World J Gastroenterol; 2008 Oct; 14(37):5650-6. PubMed ID: 18837080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A cancer mutation promotes EphA4 oligomerization and signaling by altering the conformation of the SAM domain.
    Light TP; Gomez-Soler M; Wang Z; Karl K; Zapata-Mercado E; Gehring MP; Lechtenberg BC; Pogorelov TV; Hristova K; Pasquale EB
    J Biol Chem; 2021 Jul; 297(1):100876. PubMed ID: 34139238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure and inhibitory effects on angiogenesis and tumor development of a new vascular endothelial growth inhibitor.
    Zilberberg L; Shinkaruk S; Lequin O; Rousseau B; Hagedorn M; Costa F; Caronzolo D; Balke M; Canron X; Convert O; Laïn G; Gionnet K; Goncalvès M; Bayle M; Bello L; Chassaing G; Deleris G; Bikfalvi A
    J Biol Chem; 2003 Sep; 278(37):35564-73. PubMed ID: 12837752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EphA4-mediated Rho activation via Vsm-RhoGEF expressed specifically in vascular smooth muscle cells.
    Ogita H; Kunimoto S; Kamioka Y; Sawa H; Masuda M; Mochizuki N
    Circ Res; 2003 Jul; 93(1):23-31. PubMed ID: 12775584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of axonal EphA4 forward signaling is involved in the effect of EphA3 on chicken retinal ganglion cell axon growth during retinotectal mapping.
    Fiore L; Medori M; Spelzini G; Carreño CO; Carri NG; Sanchez V; Scicolone G
    Exp Eye Res; 2019 Jan; 178():46-60. PubMed ID: 30237102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tylophorine, a phenanthraindolizidine alkaloid isolated from Tylophora indica exerts antiangiogenic and antitumor activity by targeting vascular endothelial growth factor receptor 2-mediated angiogenesis.
    Saraswati S; Kanaujia PK; Kumar S; Kumar R; Alhaider AA
    Mol Cancer; 2013 Jul; 12():82. PubMed ID: 23895055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of the Jak/Stat proteins as novel downstream targets of EphA4 signaling in muscle: implications in the regulation of acetylcholinesterase expression.
    Lai KO; Chen Y; Po HM; Lok KC; Gong K; Ip NY
    J Biol Chem; 2004 Apr; 279(14):13383-92. PubMed ID: 14729671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential expression of Eph receptors and ephrins in the cochlear ganglion and eighth cranial nerve of the chick embryo.
    Siddiqui SA; Cramer KS
    J Comp Neurol; 2005 Feb; 482(4):309-19. PubMed ID: 15669077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PEGylation potentiates the effectiveness of an antagonistic peptide that targets the EphB4 receptor with nanomolar affinity.
    Noberini R; Mitra S; Salvucci O; Valencia F; Duggineni S; Prigozhina N; Wei K; Tosato G; Huang Z; Pasquale EB
    PLoS One; 2011; 6(12):e28611. PubMed ID: 22194865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling.
    Zhou X; Yue GG; Liu M; Zuo Z; Lee JK; Li M; Tsui SK; Fung KP; Sun H; Pu J; Lau CB
    Oncotarget; 2016 Dec; 7(50):82820-82835. PubMed ID: 27756875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycoengineering of EphA4 Fc leads to a unique, long-acting and broad spectrum, Eph receptor therapeutic antagonist.
    Pegg CL; Cooper LT; Zhao J; Gerometta M; Smith FM; Yeh M; Bartlett PF; Gorman JJ; Boyd AW
    Sci Rep; 2017 Jul; 7(1):6519. PubMed ID: 28747680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression and activation of EphA4 in the human brain after traumatic injury.
    Frugier T; Conquest A; McLean C; Currie P; Moses D; Goldshmit Y
    J Neuropathol Exp Neurol; 2012 Mar; 71(3):242-50. PubMed ID: 22318127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of EphA 4 kinase activity is required for a subset of axon guidance decisions suggesting a key role for receptor clustering in Eph function.
    Egea J; Nissen UV; Dufour A; Sahin M; Greer P; Kullander K; Mrsic-Flogel TD; Greenberg ME; Kiehn O; Vanderhaeghen P; Klein R
    Neuron; 2005 Aug; 47(4):515-28. PubMed ID: 16102535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meltrin beta/ADAM19 interacting with EphA4 in developing neural cells participates in formation of the neuromuscular junction.
    Yumoto N; Wakatsuki S; Kurisaki T; Hara Y; Osumi N; Frisén J; Sehara-Fujisawa A
    PLoS One; 2008 Oct; 3(10):e3322. PubMed ID: 18830404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The EphA4 receptor regulates dendritic spine remodeling by affecting beta1-integrin signaling pathways.
    Bourgin C; Murai KK; Richter M; Pasquale EB
    J Cell Biol; 2007 Sep; 178(7):1295-307. PubMed ID: 17875741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SORLA attenuates EphA4 signaling and amyloid β-induced neurodegeneration.
    Huang TY; Zhao Y; Jiang LL; Li X; Liu Y; Sun Y; Piña-Crespo JC; Zhu B; Masliah E; Willnow TE; Pasquale EB; Xu H
    J Exp Med; 2017 Dec; 214(12):3669-3685. PubMed ID: 29114064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EphA4 may contribute to microvessel remodeling in the hippocampal CA1 and CA3 areas in a mouse model of temporal lobe epilepsy.
    Feng L; Shu Y; Wu Q; Liu T; Long H; Yang H; Li Y; Xiao B
    Mol Med Rep; 2017 Jan; 15(1):37-46. PubMed ID: 27959424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crystal structure of the EphA4 protein tyrosine kinase domain in the apo- and dasatinib-bound state.
    Farenc C; Celie PH; Tensen CP; de Esch IJ; Siegal G
    FEBS Lett; 2011 Nov; 585(22):3593-9. PubMed ID: 22036717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.